<DOC>
	<DOCNO>NCT01654068</DOCNO>
	<brief_summary>The purpose study determine Conformal High Dose Intensity Modulated Radiation Therapy appropriate option treat cancer spread spinal column . This study involve patient diagnosed metastatic cancer thoracic lumbar vertebral body level currently symptom cause area concern . The goal prove safe form treatment , Conformal High Dose Intensity Modulated Radiation Therapy reduce risk cancer come back area investigator treat may reduce risk develop symptom like pain future .</brief_summary>
	<brief_title>Conformal High Dose Intensity Modulated Radiation Therapy Disease Thoracic Lumbar Spine</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Histological confirmation malignancy ( nonsmall cell lung cancer , breast cancer ( hormone refractory ) , prostate cancer ( hormone refractory ) , lymphoma , renal cell carcinoma , myeloma either biopsy cytology primary metastatic lesion . Patients must radiological documentation metastatic disease thoracic lumbar spine include positron emit tomography ( PET ) nuclear medicine bone scan ( NMBS ) Magnetic Resonance Imaging ( MRI ) within 4 week prior study entry . Patients one three spinal metastasis thoracic lumbar spine include . Spinal metastatic lesion limit one vertebral body level ≤ 6cm great dimension . Tumors directly abut spinal cord , least 5mm separation spinal cord . For patient tumor closer 5mm , inclusion permissible discretion treat radiation oncologist dosimetric review demonstrate total dose spinal cord within tolerable range &lt; 10Gy 10 % partial volume max point dose 18 Gy . Patients must able fit either Elekta Stereotactic Body Frame Elekta Stereotactic BodyFix immobilization device . Must ≥ 18 year age . ECOG status 02 . Women childbearing potential male participant must use effective contraception method . ( Until least 60 day follow treatment . ) Negative urine pregnancy test within least one week start treatment woman childbearing age . Patients must sign studyspecific inform consent form . Patients evidence spinal instability OR neurologic deficit result bony compression neurologic structure . Patients systemic illness , recover adequately primary treatment evidence progression current cancer prior therapy , investigator 's opinion , would preclude inclusion . Patient may receive concomitant cytotoxic antineoplastic therapy treatment . Patients may allow use hormonal suppression therapy bisphosphonates hypercalcemia . Pregnant lactating woman . Any patient symptom pain , compression fracture , neurologic deficit include . Patients previously treat radiation therapy thoracic lumbar spinal level involve disease include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Female Breast Cancer</keyword>
	<keyword>Kidney Cancer</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Vertebral metastasis</keyword>
</DOC>